In an era when increasing demands are being made on the world’s healthcare services, generic medicines provide a major benefit to society by ensuring patient access to quality, safe and effective medicines while reducing the cost of pharmaceutical care.
The International Generic Pharmaceutical Alliance was born as an international network of generic medicines associations, committed to promoting generic medicines and exchanging information worldwide.
Statement by the International Generic Pharmaceutical Alliance (IGPA), Regarding the Trans-Pacific PartnershipJune 30, 2015 – The International Generic Pharmaceutical Alliance (IGPA) urges negotiators for the Trans-Pacific Partnership (TPP) not to abandon the needs of millions of the world’s citizens for access to affordable medicines. Read More
IGPA Files Recommendations for USTR 2015 Special 301 ReviewFebruary 13, 2015 – IGPA has filed its inaugural submission with the Office of the United States Trade Representative (USTR) as part of USTR`s 2015 Special 301 Review. The IGPA submission identifies a number of trade barriers and impediments for the… Read More
Growing support for shared ethical principles from healthcare and medicines providersJanuary 26, 2015 - The International Hospital Federation (IHF) and the International Generic Pharmaceutical Alliance (IGPA) endorse efforts by organizations representing patients, health professionals and R&D pharma to recognize common ethical principles worldwide when delivering solutions to address patients’ needs. Global… Read More
17th Annual IGPA Conference to Feature Global Generic Drug Industry ExpertsMIAMI, FLORIDA (November 19, 2014) — Today, the International Generic Pharmaceutical Alliance (IGPA) commences its 17th Annual Conference, bringing together company executives, regulators, national authorities and other global leaders in the generic drug industry. Read More
IGPA calls for equal status for generics industry at global pharmaceutical standards organization meetingLISBON, PORTUGAL (November 10, 2014) - Generics are more than 50% of global prescriptions, equal participation in all aspects of management and standards-setting in International Conference on Harmonization best serves public health. Read More